公开(公告)号：US20240188873A1

公开(公告)日：2024-06-13

申请号：US18510747

申请日：2023-11-16

Applicant: ZOLL Medical Corporation

Inventor： Jason T Whiting ,  Thomas E Kaib ,  Rachel H Carlson ,  Gregory R Frank

IPC: A61B5/282 ,  A61B5/00 ,  A61B5/361 ,  A61N1/04 ,  A61N1/362 ,  A61N1/365 ,  A61N1/37 ,  A61N1/39

CPC classification number: A61B5/282 ,  A61B5/361 ,  A61B5/6831 ,  A61N1/046 ,  A61N1/0484 ,  A61N1/3621 ,  A61N1/3625 ,  A61N1/36592 ,  A61N1/371 ,  A61N1/3925 ,  A61N1/3987 ,  A61B2562/17

Abstract: A non-invasive bodily-attached ambulatory medical monitoring and treatment device with pacing is provided. The noninvasive ambulatory pacing device includes a battery, at least one therapy electrode coupled to the battery, a memory storing information indicative of a patient's cardiac activity, and at least one processor coupled to the memory and the at least one therapy electrode. The at least one processor is configured to identify a cardiac arrhythmia within the information and execute at least one pacing routine to treat the identified cardiac arrhythmia.

公开(公告)号：US11998752B2

公开(公告)日：2024-06-04

申请号：US17720146

申请日：2022-04-13

Applicant: West Affum Holdings DAC

Inventor： Kenneth F. Cowan ,  Steven E. Sjoquist ,  Zoie R. Engman ,  Erick M. Roane ,  Laura M. Gustavson ,  Douglas K. Medema ,  Garrett M. Kotlarchik ,  Pamela Breske ,  Jonathan P. Niegowski ,  Joseph L. Sullivan ,  Robert R. Buchanan

IPC: A61B5/00 ,  A61B5/01 ,  A61B5/0205 ,  A61B5/1455 ,  A61B5/282 ,  A61B5/361 ,  A61B5/363 ,  A61B5/366 ,  A61N1/39 ,  A61B5/021 ,  A61B5/024 ,  A61B5/08

CPC classification number: A61N1/3987 ,  A61B5/0004 ,  A61B5/01 ,  A61B5/02055 ,  A61B5/14552 ,  A61B5/282 ,  A61B5/361 ,  A61B5/363 ,  A61B5/366 ,  A61B5/6805 ,  A61N1/3904 ,  A61N1/3925 ,  A61N1/3968 ,  A61B5/021 ,  A61B5/024 ,  A61B5/0809 ,  A61B5/6824 ,  A61B5/6828 ,  A61B5/6829 ,  A61B2562/0271

Abstract: A wearable cardioverter defibrillator (WCD) system comprises a plurality of patient parameter electrodes and a plurality of defibrillator electrodes to contact a patient's skin when the WCD is delivering therapy to the patient, a processor to receive one or more patient parameters from the one or more patient parameter electrodes, an energy storage device to store a charge to provide electrical therapy to the patient via the plurality of defibrillator electrodes, and a non-invasive blood pressure (NIBP) monitor to obtain a blood pressure measurement of the patient and to provide the blood pressure measurement to the processor. The processor is to determine whether to provide electrical therapy to the patient based on the one or more patient parameters during an episode, and to obtain the blood pressure measurement from the NIBP monitor during the episode.

公开(公告)号：US20240164722A1

公开(公告)日：2024-05-23

申请号：US18396228

申请日：2023-12-26

Applicant: ZOLL Medical Corporation

Inventor： Jeffery T. Mitchell ,  Michael A. Sipe ,  Francesco Nicolo

IPC: A61B5/00 ,  A61B5/316 ,  A61B5/361

CPC classification number: A61B5/7203 ,  A61B5/0006 ,  A61B5/316 ,  A61B5/361 ,  A61B5/7264 ,  G16H10/60

Abstract: An ECG processing system for identifying noisy ECG data segments is provided. The ECG processing system includes a network interface and a processor. The network interface is configured to receive a first collection of ECG data segments from wearable medical devices associated with a plurality of patients, each wearable medical device of the wearable medical devices being configured to be continuously worn by a patient for an extended period of time. The processor is configured to produce a second collection of ECG data segments from the first collection of ECG data segments that excludes noisy ECG data segments.

公开(公告)号：US11980472B2

公开(公告)日：2024-05-14

申请号：US17192961

申请日：2021-03-05

Applicant: Pacesetter, Inc.

Inventor： Jong Gill ,  Kyungmoo Ryu ,  Fady Dawoud

IPC: A61B5/36 ,  A61B5/00 ,  A61B5/11 ,  A61B5/361 ,  A61B5/363

CPC classification number: A61B5/363 ,  A61B5/0006 ,  A61B5/1117 ,  A61B5/361 ,  A61B5/4836 ,  A61B5/686 ,  A61B2562/0219

Abstract: A system for verifying a candidate pathologic episode of a patient is provided. The system includes an accelerometer configured to be implanted in the patient, the accelerometer configured to obtain accelerometer data along at least one axis. The system also includes a memory configured to store program instructions and one or more processors. When executing the program instructions, the one or more processors are configured to obtain a biological signal and identify a candidate pathologic episode based on the biological signal, analyze the accelerometer data to identify a physical action experienced by the patient, and verify the candidate pathologic episode based on the physical action.

公开(公告)号：US11980452B2

公开(公告)日：2024-05-14

申请号：US17307494

申请日：2021-05-04

Applicant: ACS DIAGNOSTICS, INC.

Inventor： Loren A. Manera

IPC: A61B5/0245 ,  A61B5/00 ,  A61B5/276 ,  A61B5/304 ,  A61B5/316 ,  A61B5/332 ,  A61B5/333 ,  A61B5/349 ,  A61B5/361 ,  A61B5/363

CPC classification number: A61B5/0245 ,  A61B5/0006 ,  A61B5/276 ,  A61B5/304 ,  A61B5/316 ,  A61B5/332 ,  A61B5/333 ,  A61B5/349 ,  A61B5/361 ,  A61B5/363 ,  A61B5/6823 ,  A61B2505/07 ,  A61B2560/0431

Abstract: A system and method for a multi-function remote ambulatory cardiac monitoring system. The system includes a housing and a microprocessor disposed within the housing. The microprocessor controls the remote ambulatory cardiac monitoring system. The system also includes an electrode for sensing ECG signals and the electrode being in communication with the microprocessor. An integrated cellular module also is included in the system, and the cellular module is connected to the microprocessor and disposed within the housing. The integrated cellular module transmits ECG signals to a remote center.

公开(公告)号：US11975202B2

公开(公告)日：2024-05-07

申请号：US18222621

申请日：2023-07-17

Applicant: Xyra, LLC

Inventor： Pascal Druzgala ,  Peter Gerard Milner

IPC: A61N1/36 ,  A61B5/361 ,  A61N1/362 ,  G16H40/67

CPC classification number: A61N1/3627 ,  A61B5/361 ,  G16H40/67

Abstract: Disclosed are methods to treat patients with AFib by monitoring their heart rhythm to determine the presence and/or the number of episodes of long duration AFib, and optionally the extent of AFib burden. Patients who meet threshold requirements are qualified for the treatment of AFib with a dosage of budiodarone. Patient monitoring is continued in order confirm that the patient is and remains responsive to budiodarone therapy including dose adjusting the patient to achieve such therapy. Subsequently, monitoring is continued to confirm that the patient remains responsive. These methods allow for treatment of the AFib and, correspondingly, reduce or delay the risk of stroke and/or congestive heart failure in the treated patient.

公开(公告)号：US20240138737A1

公开(公告)日：2024-05-02

申请号：US18407157

申请日：2024-01-08

Applicant: Medtronic, Inc.

Inventor： Shantanu Sarkar ,  Douglas A. Hettrick ,  Robert W. Stadler

IPC: A61B5/287 ,  A61B5/00 ,  A61B5/0205 ,  A61B5/021 ,  A61B5/0537 ,  A61B5/0538 ,  A61B5/08 ,  A61B5/11 ,  A61B5/361 ,  A61B5/363 ,  A61M5/172 ,  A61M37/00 ,  A61N1/365

CPC classification number: A61B5/287 ,  A61B5/0205 ,  A61B5/021 ,  A61B5/0537 ,  A61B5/0538 ,  A61B5/08 ,  A61B5/1118 ,  A61B5/361 ,  A61B5/363 ,  A61B5/7275 ,  A61M5/1723 ,  A61M37/00 ,  A61N1/36585 ,  A61B2562/0219 ,  A61M2230/04 ,  A61M2230/42

Abstract: Techniques for using multiple physiological parameters to provide an early warning for worsening heart failure are described. A medical device monitors a primary diagnostic parameter that is indicative of worsening heart failure, such as intrathoracic impedance or pressure, and one or more secondary diagnostic parameters. The medical device detects worsening heart failure in the patient based on the primary diagnostic parameter when an index that is changed over time based on the primary diagnostic parameter value is outside a range of values, termed the threshold zone. When the index is within the threshold zone, the medical device detects worsening heart failure in the patient based on the one or more secondary diagnostic parameters. Upon detecting worsening heart failure, the medical device may, for example, provide an alert that enables the patient to seek medical attention before experiencing a heart failure event.

公开(公告)号：US11969607B2

公开(公告)日：2024-04-30

申请号：US17194871

申请日：2021-03-08

Applicant: WEST AFFUM HOLDINGS DAC

Inventor： Joseph L. Sullivan ,  Jaeho Kim

IPC: A61N1/39 ,  A61B5/00 ,  A61B5/0205 ,  A61B5/361 ,  A61B5/363 ,  A61N1/04 ,  A61B5/11

CPC classification number: A61N1/3987 ,  A61B5/0205 ,  A61B5/361 ,  A61B5/363 ,  A61B5/4836 ,  A61N1/0484 ,  A61N1/3975 ,  A61B5/1118 ,  A61B5/6805 ,  A61B5/6823 ,  A61N1/3904 ,  A61N1/3956 ,  A61N1/3968

Abstract: A Wearable Cardioverter Defibrillator (WCD) system has a processor that performs two different analyses to an ECG of the patient. A first-level analysis can be computationally economical, while a fuller second-level analysis can give shock/no-shock advice with more certainty. In some of these embodiments the second-level analysis of the ECG is performed only if the first-level analysis of the ECG detects a possible shockable condition. As such, the first-level analysis may operate as a gatekeeping function, often preventing the more computationally intensive second-level analysis from being performed. An advantage can be that the WCD system needs to store less charge, for powering the processor. In turn, this permits portions of the WCD system to be less bulky and weigh less.

公开(公告)号：US20240074690A1

公开(公告)日：2024-03-07

申请号：US18506530

申请日：2023-11-10

Applicant: ZOLL Medical Corporation

Inventor： Michael J Gabrin ,  Christopher L Swenglish ,  Gary A Freeman

IPC: A61B5/361 ,  A61B5/00 ,  A61B5/346 ,  A61N1/04 ,  A61N1/39

CPC classification number: A61B5/361 ,  A61B5/346 ,  A61B5/6805 ,  A61B5/6831 ,  A61N1/0484 ,  A61N1/3904 ,  A61B5/282 ,  A61B5/6823 ,  A61N1/046

Abstract: An ergonomic and unobtrusive cardiac monitoring and treatment device for continuous wear includes a band configured to be worn about a thoracic region of a patient within a T1 thoracic vertebra region to a T12 thoracic vertebra region. The band includes a vertical span of between 1 to 15 centimeters along at least 50 percent of a length of the band and is configured to be immobilized relative to a skin surface of the thoracic region by exerting one or more compression forces. The device also includes electrodes and associated circuitry disposed about the band, one or more sensor ports for receiving one or more physiological sensors separate from ECG sensing electrodes, and a controller. The controller includes an ingress-protected housing and a processor configured to analyze ECG information of the patient, detect one or more treatable arrhythmias based on the ECG information, and cause delivery of electrotherapy.

公开(公告)号：US11911165B2

公开(公告)日：2024-02-27

申请号：US17115561

申请日：2020-12-08

Applicant: Samsung Electronics Co., Ltd.

Inventor： Viswam Nathan ,  Li Zhu ,  Md Mahbubur Rahman ,  Jilong Kuang ,  Jun Gao

IPC: A61B5/361 ,  G16H50/30 ,  G16H50/70 ,  G16H10/60 ,  A61B5/00 ,  A61B5/11 ,  G16H40/67 ,  G16H50/50 ,  A61B5/339 ,  G16H20/30

CPC classification number: A61B5/361 ,  A61B5/1118 ,  A61B5/339 ,  A61B5/486 ,  A61B5/6898 ,  G16H10/60 ,  G16H20/30 ,  G16H40/67 ,  G16H50/30 ,  G16H50/50 ,  G16H50/70

Abstract: A method includes estimating, by a consumer electronic device, an atrial fibrillation (AF) burden of a subject based on multiple measurements passively collected by at least one sensor associated with the consumer electronic device while the subject is in a free-living environment. The method also includes outputting, by the consumer electronic device, an AF burden notification associated with the subject based on the estimated AF burden. The method further includes outputting, by the consumer electronic device, an AF burden recommendation based on the estimated AF burden.